期刊文献+

不同血浆代用品体外循环预充对3岁以下婴幼儿肝功能及凝血功能的影响 被引量:3

Effects of different colloids in extracorporeal circulation priming solution on hepatic function and coagulation function in infants less than 3 years
暂未订购
导出
摘要 目的探讨6%羟乙基淀粉130/0.4(万汶)和琥珀酰明胶(血定安)预充对于3岁以下先天性心脏病(先心病)手术患儿肝功能及凝血功能的影响。方法 45例年龄≤3岁的非紫绀型先心病患者,按照随机数字法分为3组:羟乙基淀粉组(H组)、琥珀酰明胶组(G组)和血浆对照组(C组),每组15例。分别于术前(T0)、术后2 h(T1)、术后24 h(T2)及48 h(T3)采动脉血检测患者总胆红素(TBIL)、直接胆红素(DBIL)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、凝血酶原时间(PT)、纤维蛋白原含量(FIB)、活化部分凝血酶时间(APTT)和凝血酶时间(TT)。结果三组患儿术后TBIL、DBIL和AST均明显升高,ALTH组和C组降低而G组升高(P<0.01),PT、TT明显延长,FIB显著升高(P<0.01);H组各项指标变化水平均低于C组(P<0.05)。结论 6%羟乙基淀粉130/0.4和琥珀酰明胶用于3岁以下先心病婴幼儿体外循环预充,对其肝功能和凝血功能存在不同程度的亚临床损害,且潜在损害6%羟乙基淀粉130/0.4小于琥珀酰明胶。 OBJECTIVE To evaluate the effects of hydroxyethyl starch 130/0.4(HES) and succinyl gelatin used as priming solution for extracorporeal circulation(ECC) on hepatic function and coagulation function in infants with congenital heart disease less than 3 years.METHODS 45 infants with non-cyanosed congenital heart disease undergoing cardiac surgery with ECC were randomly divided into 3 groups(n=15 in each group): HES group,GEL group and plasma group.Blood samples were taken from the arterial at before surgery(T0),2 hours(T1),24 hours(T2) and 48 hours(T3) after the end of operation for total bilirubin(TBIL),direct bilirubin(DBIL),alanine aminotransferase(ALT),aspartate aminotransferase(AST),prothrombin time(PT),activated partial thromboplastin time(APTT),fibrinogen(FIB) and thrombin time(TT) monitoring.RESULTS After operation,the serum TBIL,DBIL and AST levels were significant higher in 3 groups.Compared with that in the plasma group,the level of ALT obviously decreased,PT,TT and FIB were significant increased after operation in the HES and plasma group,and all theses changes were more significantly in HES group than that in plasma group.CONCLUSION Using HES and GEL as priming fluid for ECC had inequality degree potential clinic damage on hepatic function and coagulation function in infants.Compared with GEL,the potential clinical consequences of HES were lighter.
出处 《中国体外循环杂志》 2011年第1期16-19,56,共5页 Chinese Journal of Extracorporeal Circulation
关键词 体外循环 肝功能 凝血功能 血浆代用品 婴幼儿 Extracorporeal circulation Hepatic function Coagulation Colloids Infant
  • 相关文献

参考文献16

  • 1Wiesen P, Canivet JL, Ledoux D. et al. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study [ J ]. Acta Anaesthesiol Belg,2005,56 ( 3 ) :257 263.
  • 2黄贞玲,王珊娟,杭燕南,孙大金.羟乙基淀粉与明胶对体外循环心内直视术病人凝血和肾功能的影响[J].临床麻醉学杂志,2001,17(8):427-430. 被引量:16
  • 3Boldt J, Brosch C, Ducke M, et al. Influence of volume therapy with a modem hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin [ J ]. Crit Care Med, 2007,35 (12) :2740 -2746.
  • 4Boldt J, Suttner S, Brosch C, et al. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin -based priming strategy[J]. Anesth Analg, 2009,109(6) :1752 1762.
  • 5刘慧丽,苗齐,曹丽华,罗爱伦,黄宇光.羟乙基淀粉对体外循环后急性炎性反应的影响[J].中国体外循环杂志,2007,5(3):146-149. 被引量:2
  • 6潘四新,薛玉良,王辉.6%羟已基淀粉130/0.4体外循环预充对心脏手术患儿肝肾功能及凝血功能的影响[J].中国体外循环杂志,2009,7(1):16-19. 被引量:1
  • 7Yamada T, Ochiai R, Takeda J, et al. Off pump coronary artery bypass attenuates transient hepatocellular damage after myocardial revascularization [ J ]. J Cardiothorac Vasc Anesth, 2005,19(5) :603 -607.
  • 8Leusehner J, Opitz J, Winkler A, et al. Tissue storage of 14C labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/ O. 5 after repeated intravenous administration to rats[ J]. Drugs R D,2003,4(6) :331 -338.
  • 9Christidis C, Mal F, Ramos J, et al. Worsening of hepatic dysfunction as a consequence of repeated hydrexyethylstarch infusions[J]. J Hepatol,2001 ,35(6) :726 -732.
  • 10Miller RD,主编.曾因明,邓小明,译.米勒麻醉学[M].第6版.北京大学医学出版社,2006:324-332.

二级参考文献49

  • 1王东霞.血浆纤维蛋白与年龄关系的研究[J].中国厂矿医学,2006,19(5):403-404. 被引量:7
  • 2Christoph JK,Timo JM,Guido KS,et al.In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated ringer's solution on coagulation using Sonoclot[J].Anesth Analg,2000,90(2):274-279.
  • 3Jungheinrich C,Sauermann W,Beperling F,et al.Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4(6%) with anoptimised in vivo molecular weight in orthopaedic surgery-a randomized,double-blind study[J].Drugs RD,2004,5(1):1-9.
  • 4Langeron O,Doelberg M,Ang ET,et al.Voluven,a lower substituted novel hydroxyethyl starch (HES 130/0.4) cause fewer effects on coagulation in major orthopedic surgery than HES 200/0.5[J].Anesth Analg,2001,92(4):855-862.
  • 5Kasper SM,Meinert P,Kampe S,et al.Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses[J].Anesthesiology,2003,99(1):42-47.
  • 6Treib J,Haass A,Pindur G,et al.Highly substituted hydroxyethyl starch (HES 200/0.62) leads to a typeⅠ von Willebrand syndrome after repeated administration[J].Hemostasis,1996,26(4):210-213.
  • 7Stoll M,Treib J,Schenk F,et al.No coagulation disorders under high dose volume therapy with low molecular weight hydroxyethyl starch[J].Hemostasis,1997,27(5):251-258.
  • 8Treib J,Haass A,Pindur G,et al.Increased hemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch[J].Arzneim Forsch/Drug Res,1997,47(1):18-22.
  • 9Treib J,Haass A,Pindur G,et al.A more differentiated classification of hydroxyethyl starch is nessessary[J].Intens Care Med,1997,23(6):709-710.
  • 10Treib J,Haass A,Pindur G,et al.Coagulation disorders caused by hydroxyethyl starch[J].Thromb Haemost,1997,78(3):974-983.

共引文献75

同被引文献59

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部